Re-biopsy confers survival benefit through directing salvage treatment for patients failing prior EGFR-TKIs

Re-biopsy confers survival benefit through directing salvage treatment for patients failing prior EGFR-TKIs is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Re-biopsy confers survival benefit through directing salvage treatment for patients failing prior EGFR-TKIs have?

Re-biopsy confers survival benefit through directing salvage treatment for patients failing prior EGFR-TKIs has 2 citations in the OpenAlex counts ScholarIQ stores.

When was Re-biopsy confers survival benefit through directing salvage treatment for patients failing prior EGFR-TKIs published?

Re-biopsy confers survival benefit through directing salvage treatment for patients failing prior EGFR-TKIs has 2016 year in the ScholarIQ index.

What is the open-access status of Re-biopsy confers survival benefit through directing salvage treatment for patients failing prior EGFR-TKIs?

Re-biopsy confers survival benefit through directing salvage treatment for patients failing prior EGFR-TKIs has bronze oa status in the ScholarIQ index.

What is the DOI of Re-biopsy confers survival benefit through directing salvage treatment for patients failing prior EGFR-TKIs?

The DOI for Re-biopsy confers survival benefit through directing salvage treatment for patients failing prior EGFR-TKIs is on the source record.

What is the OpenAlex record for Re-biopsy confers survival benefit through directing salvage treatment for patients failing prior EGFR-TKIs?

The OpenAlex for Re-biopsy confers survival benefit through directing salvage treatment for patients failing prior EGFR-TKIs is on the source record.